{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:07:53Z","timestamp":1790118473093,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,7]],"date-time":"2013-07-07T00:00:00Z","timestamp":1373155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AGE"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s11357-013-9554-7","type":"journal-article","created":{"date-parts":[[2013,7,6]],"date-time":"2013-07-06T03:26:09Z","timestamp":1373081169000},"page":"265-274","source":"Crossref","is-referenced-by-count":20,"title":["Short-term effects of low-dose estrogen\/drospirenone vs low-dose estrogen\/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome"],"prefix":"10.1007","volume":"36","author":[{"given":"Maria Rosaria","family":"Rizzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"De Franciscis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Colacurci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Paolisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,7]]},"reference":[{"key":"9554_CR1","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","volume":"366","author":"KG Alberti","year":"2005","unstructured":"Alberti KG, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome: a new worldwide definition. Lancet 366:1059\u20131062","journal-title":"Lancet"},{"issue":"1","key":"9554_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijgo.2012.02.016","volume":"118","author":"AC Can\u00e1rio","year":"2012","unstructured":"Can\u00e1rio AC, Cabral PU, Spyrides MH, Giraldo PC, Eleut\u00e9rio J Jr, Gon\u00e7alves AK (2012) The impact of physical activity on menopausal symptoms in middle-aged women. Int J Gynaecol Obstet 118(1):34\u201336","journal-title":"Int J Gynaecol Obstet"},{"issue":"6","key":"9554_CR3","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1210\/jc.2003-030242","volume":"88","author":"MC Carr","year":"2003","unstructured":"Carr MC (2003) The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88(6):2404\u20132411","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"9554_CR4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.fertnstert.2008.06.049","volume":"92","author":"G Casanova","year":"2009","unstructured":"Casanova G, Radavelli S, Lhullier F, Spritzer PM (2009) Effects of non-oral estradiol-micronized progesterone or low-dose oral estradiol\u2013drospirenone therapy on metabolic variables and markers of endothelial function in early post menopause. Fertil Steril 92(2):605\u2013612","journal-title":"Fertil Steril"},{"issue":"5","key":"9554_CR5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2005.08.012","volume":"97","author":"BN Chakravarty","year":"2005","unstructured":"Chakravarty BN, Shirazee HH, Dam P, Goswami SK, Chatterjee R, Ghosh S (2005) Oral dydrogesterone versus intravaginal micronized progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomized study. J Steroid Biochem Mol Biol 97(5):416\u2013420","journal-title":"J Steroid Biochem Mol Biol"},{"key":"9554_CR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2147\/DMSO.S3812","volume":"1","author":"J Churruca","year":"2008","unstructured":"Churruca J, Vigil L, Luna E, Ruiz-Galiana J, Varela M (2008) The route to diabetes: loss of complexity in the glycemic profile from health through the metabolic syndrome to type 2 diabetes. Diabetes Metab Syndr Obes 1:3\u201311","journal-title":"Diabetes Metab Syndr Obes"},{"key":"9554_CR7","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1093\/eurheartj\/ehm296","volume":"28","author":"P Collins","year":"2007","unstructured":"Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, Kaaja R, Mikkola T, Palacios S, Preston R, Simon T, Stevenson J, Stramba-Badiale M (2007) Management of cardiovascular risk in the peri-menopausal woman: a consensus statement of European cardiologists and gynaecologists. Eur Heart J 28:2028\u20132040","journal-title":"Eur Heart J"},{"issue":"2","key":"9554_CR8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","volume":"22","author":"M Coutinho","year":"1999","unstructured":"Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999) The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care 22(2):233\u2013240","journal-title":"Diabetes Care"},{"key":"9554_CR9","doi-asserted-by":"crossref","unstructured":"Edwardson CL, Gorely T, Davies MJ, Gray LJ, Khunti K, Wilmot EG, Yates T, Biddle SJ (2012) Association of sedentary behaviour with metabolic syndrome: a meta-analysis. PLoS One 7(4):e34916","DOI":"10.1371\/journal.pone.0034916"},{"key":"9554_CR10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/09513590701582323","volume":"23","author":"JM Foidart","year":"2007","unstructured":"Foidart JM, Faustmann T (2007) Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen. Gynecol Endocrinol 23:692\u2013699, Review","journal-title":"Gynecol Endocrinol"},{"key":"9554_CR11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","volume":"54","author":"U Fuhrmann","year":"1996","unstructured":"Fuhrmann U, Krattenmacher R, Slater EP, Fritzemeier KH (1996) The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 54:243\u2013251","journal-title":"Contraception"},{"issue":"3","key":"9554_CR12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0378-5122(95)00901-V","volume":"21","author":"UJ Gaspard","year":"1995","unstructured":"Gaspard UJ, Gottal JM, van den Br\u00fble FA (1995) Postmenopausal changes of lipid and glucose metabolism: a review of their main aspects. Maturitas 21(3):171\u2013178","journal-title":"Maturitas"},{"issue":"2","key":"9554_CR13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/13697139909025572","volume":"2","author":"UJ Gaspard","year":"1999","unstructured":"Gaspard UJ, Wery OJ, Scheen AJ, Jaminet C, Lefebvre PJ (1999) Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric 2(2):93\u2013100","journal-title":"Climacteric"},{"issue":"4","key":"9554_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/13697130008500127","volume":"3","author":"AR Genazzani","year":"2000","unstructured":"Genazzani AR, Gambacciani M, International Menopause Society (2000) Controversial issues in climacteric medicine I. Cardiovascular disease and hormone replacement therapy. Climacteric 3(4):233\u2013240, Review","journal-title":"Climacteric"},{"key":"9554_CR15","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/aje\/kwh250","volume":"160","author":"SH Golden","year":"2004","unstructured":"Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A (2004) Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women. Am J Epidemiol 160:540\u2013548","journal-title":"Am J Epidemiol"},{"issue":"9","key":"9554_CR16","first-page":"921e8","volume":"13","author":"NR Hill","year":"2011","unstructured":"Hill NR, Oliver NS, Choudhary P, Levy JC, Hindmarsh P, Matthews DR (2011) Normal reference range for mean tissue glucose and glycemic variability derived from continuous glucose monitoring for subjects without diabetes in different ethnic groups. Diabetes Technol Ther 13(9):921e8","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"9554_CR17","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/dia.2008.0016","volume":"10","author":"IB Hirsch","year":"2008","unstructured":"Hirsch IB, Armstrong D, Bergenstal RM, Buckingham B, Childs BP, Clarke WL, Peters A, Wolpert H (2008) Clinical application of emerging sensor technologies in diabetes management: consensus guidelines for continuous glucose monitoring (CGM). Diabetes Technol Ther 10(4):232\u2013244","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"9554_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-09-0265","volume":"161","author":"D Kronawitter","year":"2009","unstructured":"Kronawitter D, Gooren LJ, Zollver H, Oppelt PG, Beckmann MW, Dittrich R, Mueller A (2009) Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study. Eur J Endocrinol 161(2):363\u2013368","journal-title":"Eur J Endocrinol"},{"key":"9554_CR19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2004.02166.x","volume":"61","author":"S Kwok","year":"2004","unstructured":"Kwok S, Selby PL, McElduff P, Laing I, Mackness B, Mackness MI, Prais H, Morgan J, Yates AP, Durrington PN, Sci FM (2004) Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy. Clin Endocrinol 61:760\u2013767","journal-title":"Clin Endocrinol"},{"key":"9554_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2008.03498.x","volume":"71","author":"G Lastra-Lastra","year":"2009","unstructured":"Lastra-Lastra G, Sowers JR, Restrepo-Erazo K, Manrique-Acevedo C, Lastra-Gonz\u00e1lez G (2009) The role of aldosterone and angiotensin II in insulin resistance: an update. Clin Endocrinol 71:1\u20136","journal-title":"Clin Endocrinol"},{"issue":"1","key":"9554_CR21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3132\/dvdr.2008.011","volume":"5","author":"DK McGuire","year":"2008","unstructured":"McGuire DK, Winterfield J, Rytlewski JA, Ferrannini E (2008) Blocking the renin\u2013angiotensin\u2013aldosterone system to prevent diabetes mellitus. Diab Vasc Dis Res 5(1):59\u201366","journal-title":"Diab Vasc Dis Res"},{"key":"9554_CR22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.ATV.0000191656.71812.7c","volume":"26","author":"PB Mellen","year":"2006","unstructured":"Mellen PB, Cefalu WT, Herrington DM (2006) Diabetes, the metabolic syndrome, and angiographic progression of coronary arterial disease in postmenopausal women. Arterioscler Thromb Vasc Biol 26:189\u2013193","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9554_CR23","doi-asserted-by":"crossref","unstructured":"Monnier L, Colette C (2008) Glycemic variability: should we and can we prevent it? Diabetes Care 31(suppl 2):S150\u2013S154","DOI":"10.2337\/dc08-s241"},{"issue":"14","key":"9554_CR24","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","volume":"295","author":"L Monnier","year":"2006","unstructured":"Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C (2006) Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295(14):1681\u20131687","journal-title":"JAMA"},{"key":"9554_CR25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diabet.2006.11.007","volume":"33","author":"L Monnier","year":"2007","unstructured":"Monnier L, Colette C, Boegner C, Pham TC, Lapinski H, Boniface H (2007) Continuous glucose monitoring in patients with type 2 diabetes: Why? When? Whom? Diabetes Metab 33:247\u2013252","journal-title":"Diabetes Metab"},{"issue":"5","key":"9554_CR26","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1530\/eje.0.1500705","volume":"150","author":"LC Morin-Papunen","year":"2004","unstructured":"Morin-Papunen LC, Vauhkonen I, Ruokonen A, Tapanainen JS, Raudaskoski T (2004) Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study. Eur J Endocrinol 150(5):705\u2013714","journal-title":"Eur J Endocrinol"},{"key":"9554_CR27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.maturitas.2006.07.009","volume":"55","author":"S Palacios","year":"2006","unstructured":"Palacios S, Foidart JM, Genazzani AR (2006) Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism. Maturitas 55:297\u2013307","journal-title":"Maturitas"},{"key":"9554_CR28","first-page":"797","volume":"18","author":"RA Preston","year":"2005","unstructured":"Preston RA, White WB, Pitt B, Bakris G, Norris PM, Hanes V (2005) Effects of drospirenone\/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. AJH 18:797\u2013804","journal-title":"AJH"},{"key":"9554_CR29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288:321\u2013333","journal-title":"J Am Med Assoc"},{"issue":"1","key":"9554_CR30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/13697130802403994","volume":"12","author":"H Seeger","year":"2009","unstructured":"Seeger H, Wallwiener D, Mueck AO (2009) Effects of drospirenone on cardiovascular markers in human aortic endothelial cells. Climacteric 12(1):80\u201387","journal-title":"Climacteric"},{"key":"9554_CR31","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/diab.19.9.644","volume":"19","author":"FJ Service","year":"1970","unstructured":"Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF (1970) Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 19:644\u2013655","journal-title":"Diabetes"},{"key":"9554_CR32","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1089\/jwh.2006.15.584","volume":"15","author":"LP Shulman","year":"2006","unstructured":"Shulman LP (2006) A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone. J Womens Health 15:584\u2013590","journal-title":"J Womens Health"},{"key":"9554_CR33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0015-0282(01)02934-X","volume":"77","author":"CK Sites","year":"2002","unstructured":"Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, Poehlman ET (2002) Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril 77:128\u20131357","journal-title":"Fertil Steril"},{"issue":"1\u20132","key":"9554_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.maturitas.2008.11.011","volume":"61:1","author":"R Sitruk-Ware","year":"2008","unstructured":"Sitruk-Ware R (2008) Pharmacological profile of progestins. Maturitas 61:1(1\u20132):151\u2013157","journal-title":"Maturitas"},{"issue":"Suppl 2","key":"9554_CR35","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.2337\/dc11-s206","volume":"34","author":"E Standl","year":"2011","unstructured":"Standl E, Schnell O, Ceriello A (2011) Postprandial hyperglycemia and glycemic variability: should we care? Diabetes Care 34(Suppl 2):S120\u2013S127","journal-title":"Diabetes Care"},{"issue":"1","key":"9554_CR36","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.fertnstert.2010.07.001","volume":"95","author":"P Villa","year":"2011","unstructured":"Villa P, Suriano R, Ricciardi L, Tagliaferri V, De Cicco S, De Franciscis P, Colacurci N, Lanzone A (2011) A low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women. Fertil Steril 95(1):158\u2013163","journal-title":"Fertil Steril"},{"key":"9554_CR37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1161\/01.HYP.0000232179.60442.84","volume":"48","author":"WB White","year":"2006","unstructured":"White WB, Hanes V, Chauhan V, Pitt B (2006) Effects of a new hormone therapy, drospirenone and 17-betaestradiol, in postmenopausal women with hypertension. Hypertension 48:246\u2013253","journal-title":"Hypertension"}],"container-title":["AGE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-013-9554-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11357-013-9554-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-013-9554-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T06:02:09Z","timestamp":1563343329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11357-013-9554-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9554"],"URL":"https:\/\/doi.org\/10.1007\/s11357-013-9554-7","relation":{},"ISSN":["0161-9152","1574-4647"],"issn-type":[{"value":"0161-9152","type":"print"},{"value":"1574-4647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,7]]}}}